Connection

Roberto Giacomelli to Male

This is a "connection" page, showing publications Roberto Giacomelli has written about Male.
Connection Strength

0.175
  1. Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1247-1254.
    View in: PubMed
    Score: 0.012
  2. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann Rheum Dis. 2020 09; 79(9):1152-1155.
    View in: PubMed
    Score: 0.012
  3. Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study. Medicine (Baltimore). 2019 Apr; 98(15):e15123.
    View in: PubMed
    Score: 0.011
  4. IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study. Medicine (Baltimore). 2019 Feb; 98(7):e14587.
    View in: PubMed
    Score: 0.011
  5. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy. Arthritis Res Ther. 2018 10 03; 20(1):223.
    View in: PubMed
    Score: 0.011
  6. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017 Dec; 36(12):2839-2845.
    View in: PubMed
    Score: 0.010
  7. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. Medicine (Baltimore). 2017 Aug; 96(34):e7896.
    View in: PubMed
    Score: 0.010
  8. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. PLoS One. 2017; 12(7):e0181203.
    View in: PubMed
    Score: 0.010
  9. What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial. Clin Exp Rheumatol. 2017 Jul-Aug; 35(4):623-629.
    View in: PubMed
    Score: 0.010
  10. Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset. Int J Rheum Dis. 2017 Sep; 20(9):1247-1260.
    View in: PubMed
    Score: 0.010
  11. Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study. PLoS One. 2017; 12(1):e0170108.
    View in: PubMed
    Score: 0.009
  12. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers. Autoimmun Rev. 2017 Jan; 16(1):16-21.
    View in: PubMed
    Score: 0.009
  13. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 08; 7(3).
    View in: PubMed
    Score: 0.003
  14. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. Ann Rheum Dis. 2021 11; 80(11):1498-1501.
    View in: PubMed
    Score: 0.003
  15. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study. Spinal Cord Ser Cases. 2020 08 04; 6(1):69.
    View in: PubMed
    Score: 0.003
  16. Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study. Rheumatol Int. 2020 Jun; 40(6):951-958.
    View in: PubMed
    Score: 0.003
  17. Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):76-81.
    View in: PubMed
    Score: 0.003
  18. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol. 2019 May-Jun; 37 Suppl 118(3):97-106.
    View in: PubMed
    Score: 0.003
  19. Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis. J Dermatolog Treat. 2020 Nov; 31(7):692-697.
    View in: PubMed
    Score: 0.003
  20. Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions. Arthritis Rheumatol. 2018 12; 70(12):2003-2013.
    View in: PubMed
    Score: 0.003
  21. Downregulation of miRNA17-92 cluster marks V?9Vd2 T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2018 Oct 22; 20(1):236.
    View in: PubMed
    Score: 0.003
  22. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):102-112.
    View in: PubMed
    Score: 0.003
  23. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome. Arthritis Rheumatol. 2018 08; 70(8):1265-1275.
    View in: PubMed
    Score: 0.003
  24. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort. J Rheumatol. 2018 06; 45(6):864-872.
    View in: PubMed
    Score: 0.003
  25. The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study: GIRRCS=Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale. Medicine (Baltimore). 2018 Apr; 97(15):e0370.
    View in: PubMed
    Score: 0.003
  26. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. Medicine (Baltimore). 2017 Oct; 96(42):e8180.
    View in: PubMed
    Score: 0.002
  27. Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. Clin Exp Immunol. 2017 11; 190(2):208-216.
    View in: PubMed
    Score: 0.002
  28. Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol. 2018 May-Jun; 36 Suppl 112(3):73-79.
    View in: PubMed
    Score: 0.002
  29. Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue. J Rheumatol. 2017 08; 44(8):1179-1183.
    View in: PubMed
    Score: 0.002
  30. Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome. Clin Exp Rheumatol. 2017 May-Jun; 35(3):546-547.
    View in: PubMed
    Score: 0.002
  31. Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. Ann Rheum Dis. 2013 May; 72(5):782-3.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.